195 related articles for article (PubMed ID: 31978462)
1. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
Zhuang B; Chen T; Xiao Z; Jin Y
Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
[TBL] [Abstract][Full Text] [Related]
2. Chitosan Hydrogels for Synergistic Delivery of Chemotherapeutics to Triple Negative Breast Cancer Cells and Spheroids.
Schneible JD; Young AT; Daniele MA; Menegatti S
Pharm Res; 2020 Jul; 37(7):142. PubMed ID: 32661774
[TBL] [Abstract][Full Text] [Related]
3. A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer.
Vogus DR; Evans MA; Pusuluri A; Barajas A; Zhang M; Krishnan V; Nowak M; Menegatti S; Helgeson ME; Squires TM; Mitragotri S
J Control Release; 2017 Dec; 267():191-202. PubMed ID: 28823957
[TBL] [Abstract][Full Text] [Related]
4. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
5. Tailoring the Chemical Modification of Chitosan Hydrogels to Fine-Tune the Release of a Synergistic Combination of Chemotherapeutics.
Schneible JD; Singhal A; Lilova RL; Hall CK; Grafmüller A; Menegatti S
Biomacromolecules; 2019 Aug; 20(8):3126-3141. PubMed ID: 31310515
[TBL] [Abstract][Full Text] [Related]
6. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
[TBL] [Abstract][Full Text] [Related]
7. [An injectable hydrogel/staple fiber composite for sustained release of CA4P and doxorubicin for combined chemotherapy of xenografted breast tumor in mice].
Wang T; Yang L; Xie Y; Cheng S; Xiong M; Luo X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):625-632. PubMed ID: 35673904
[TBL] [Abstract][Full Text] [Related]
8. An injectable hydrogel with pH-sensitive and self-healing properties based on 4armPEGDA and N-carboxyethyl chitosan for local treatment of hepatocellular carcinoma.
Zhan J; Wu Y; Wang H; Liu J; Ma Q; Xiao K; Li Z; Li J; Luo F; Tan H
Int J Biol Macromol; 2020 Nov; 163():1208-1222. PubMed ID: 32645496
[TBL] [Abstract][Full Text] [Related]
9. Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
Ni S; Qiu L; Zhang G; Zhou H; Han Y
Int J Nanomedicine; 2017; 12():1565-1576. PubMed ID: 28280326
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
[TBL] [Abstract][Full Text] [Related]
12. An injectable thermosensitive photothermal-network hydrogel for near-infrared-triggered drug delivery and synergistic photothermal-chemotherapy.
Liu C; Guo X; Ruan C; Hu H; Jiang BP; Liang H; Shen XC
Acta Biomater; 2019 Sep; 96():281-294. PubMed ID: 31319202
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Injectable Chitosan-based Co-cross-linking Hydrogel for Local Delivery of
Huang FJ; Hung CC; Chang CW; Chao JH; Hsieh BT
Anticancer Res; 2018 Aug; 38(8):4651-4659. PubMed ID: 30061232
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
[TBL] [Abstract][Full Text] [Related]
15. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
16. Dynamic-Covalent Hydrogel with NIR-Triggered Drug Delivery for Localized Chemo-Photothermal Combination Therapy.
Sun P; Huang T; Wang X; Wang G; Liu Z; Chen G; Fan Q
Biomacromolecules; 2020 Feb; 21(2):556-565. PubMed ID: 31804804
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
[TBL] [Abstract][Full Text] [Related]
19. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
20. Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors.
Qin X; He L; Feng C; Fan D; Liang W; Wang Q; Fang J
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46270-46281. PubMed ID: 34550685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
